DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer

Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study

(2018) L.R. van der Werf et al.   EUROPEAN JOURNAL OF CANCER

Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis

(2016) Peter S.N. van Rossum et al.   GASTROINTESTINAL ENDOSCOPY

Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: A pilot study

(2016) Elisabeth Weiss et al.   LUNG CANCER

Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy

(2016) Sophie E. Heethuis et al.   RADIOTHERAPY AND ONCOLOGY

Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations

(2016) Eric Karl Oermann et al.   Scientific Reports

Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer

(2015) Martijn Intven et al.   ACTA ONCOLOGICA

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer

(2015) Xia Li et al.   INVESTIGATIVE RADIOLOGY

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

(2015) Joel Shapiro et al.   LANCET ONCOLOGY

Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer

(2015) Peter S.N. van Rossum et al.   RADIOTHERAPY AND ONCOLOGY

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations

(2015) Anwar R. Padhani et al.   NEOPLASIA

Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer

(2014) Joel Shapiro et al.   ANNALS OF SURGERY

Pretreatment Diffusion-Weighted and Dynamic Contrast-Enhanced MRI for Prediction of Local Treatment Response in Squamous Cell Carcinomas of the Head and Neck

(2012) Sanjeev Chawla et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer

(2011) Monique Maas et al.   JOURNAL OF CLINICAL ONCOLOGY

Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis

(2011) Yu-mei Chen et al.   NUCLEAR MEDICINE COMMUNICATIONS

Predicting and monitoring cancer treatment response with diffusion-weighted MRI

(2010) Harriet C. Thoeny et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of18F FDG PET: A Systematic Review

(2010) Robert M. Kwee   RADIOLOGY

Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

(2009) James M. Donahue et al.   ANNALS OF THORACIC SURGERY

Simultaneous multi-modality ROI delineation in clinical practice

(2009) Gijsbert H. Bol et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Predicting radiotherapy outcomes using statistical learning techniques

(2009) Issam El Naqa et al.   PHYSICS IN MEDICINE AND BIOLOGY